Xenon Pharmaceuticals (XENE) Operating Margin Growth (5y) (2019 - 2025)

Xenon Pharmaceuticals (XENE) Operating Margin Growth (5y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Xenon Pharmaceuticals 6.03 Bn 6.03 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -85,635.00
Sep 30, 2022 -2.56 Mn
Jun 30, 2022 4.70 Mn
Mar 31, 2022 4.97 Mn
Dec 31, 2021 78,801.00
Sep 30, 2021 158,306.00
Jun 30, 2021 52,707.00
Mar 31, 2021 57,294.00
Dec 31, 2020 -17,027.00
Sep 30, 2020 -12,889.00
Jun 30, 2020 -975.00
Mar 31, 2020 3,955.00
Dec 31, 2019 -34,911.00
Sep 30, 2019 -32,139.00